CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

NICE im Vereinigten Königreich empfiehlt in neuer Leitlinie routinemäßige NHS-Finanzierung für das VitaSmart™ Hypothermic Oxygenated Perfusion System von Bridge to Life

RegulatoryapprovedVitaSmart™ Hypothermic Oxygenated Perfusion SystemPositive
AI Analysis

Summary

NICE has recommended routine NHS funding for Bridge to Life's VitaSmart Hypothermic Oxygenated Perfusion System in a new HealthTech guideline in the United Kingdom.

Outcome Details

NICE recommended routine NHS funding for VitaSmart Hypothermic Oxygenated Perfusion System in new HealthTech guideline

Importance:6/10
Sentiment:
0.80
regulatory approvalNICE recommendationNHS fundingorgan preservationmedical deviceUnited Kingdom
Related Companies
$NHPAP

Read the original article

Published by PR Newswire Biotech on August 28, 2026 3:08 PM

Read Original